Urinalysis Market Synopsis
Urinalysis Market Size Was Valued at USD 4.16 Billion in 2023, and is Projected to Reach USD 8.98 Billion by 2032, Growing at a CAGR of 8.92% from 2024-2032.
The urinalysis market is growing steadily, driven by the rising prevalence of chronic kidney diseases, diabetes, and urinary tract infections (UTIs) worldwide. Urinalysis, a diagnostic test for examining urine’s chemical, physical, and microscopic properties, plays a critical role in detecting a range of health conditions early on. As healthcare providers increasingly focus on preventive care, the demand for convenient and efficient urinalysis tests in hospitals, diagnostic labs, and even home care settings are expected to rise. The growing incidence of diseases related to lifestyle and aging populations in both developed and emerging markets further boosts the need for urinalysis testing.
Technological advancements are transforming the urinalysis market, leading to the development of automated and portable urinalysis devices. These innovations offer rapid and accurate results, enabling healthcare providers to make timely treatment decisions. Automated urinalysis analyzers, in particular, are gaining popularity in clinical laboratories due to their efficiency and ability to handle high sample volumes. Additionally, smartphone-compatible urinalysis devices are entering the market, allowing patients to self-monitor their health, especially those with chronic conditions requiring regular testing, such as diabetes and hypertension.
Geographically, North America and Europe currently lead the urinalysis market, largely due to well-established healthcare infrastructure, high awareness levels, and significant investments in diagnostics. However, the Asia-Pacific region is expected to witness rapid growth in the coming years due to rising healthcare expenditures, increasing prevalence of kidney-related diseases, and improved access to healthcare services. With the continued focus on early disease detection and ongoing technological advancements, the urinalysis market is positioned for sustained growth, making it an essential component of diagnostic healthcare globally.
Urinalysis Market Trend Analysis:
Growth of Automated and Digital Urinalysis Systems
-
The urinalysis market is witnessing a significant shift toward automation, with digital urinalysis systems becoming increasingly popular in clinical settings. Automated analyzers streamline the testing process, reduce human error, and deliver faster, more accurate results, allowing laboratories to handle larger volumes efficiently. Digital platforms and software integration further enhance the ability to store, analyze, and share test data, supporting better patient management. These systems are particularly beneficial for hospitals and diagnostic labs that require high-throughput solutions for routine testing.
Rising Demand for Home-Based and Point-of-Care Urinalysis Testing
-
Another notable trend is the growing demand for home-based and point-of-care urinalysis testing, driven by the increasing need for convenient, patient-centric healthcare. Portable urinalysis devices and smartphone-compatible testing kits allow individuals to monitor their health at home, especially those managing chronic conditions such as diabetes, kidney disease, and UTIs. This trend not only reduces the burden on healthcare facilities but also empowers patients with timely access to diagnostic information, encouraging proactive health management and facilitating early intervention.
Urinalysis Market Segment Analysis:
Urinalysis Market is Segmented on the basis of By Testing Type, Product, Modality, Application, Distribution Channel, and Region.
By Testing Type, Urine Sediment Testing segment is expected to dominate the market during the forecast period
-
In the urinalysis market, testing types are broadly categorized into urine biochemistry testing and urine sediment testing, each playing a vital role in diagnosing various health conditions. Urine biochemistry testing primarily involves chemical analysis of urine to detect substances such as glucose, protein, ketones, and specific biomarkers, making it highly useful for monitoring metabolic and chronic conditions like diabetes and kidney disease. Urine sediment testing, on the other hand, focuses on microscopic examination of solid particles in the urine, helping to identify infections, kidney disorders, and other abnormalities by detecting cells, crystals, bacteria, and other sediments. Both testing methods complement each other, offering healthcare providers a comprehensive assessment tool to detect a wide range of health issues and enhancing the diagnostic capabilities within the urinalysis market.
By Distribution Channel, Direct Tender segment expected to held the largest share
-
In the urinalysis market, distribution channels are primarily categorized into direct tender and retail sales. Direct tender refers to the procurement of urinalysis products, such as diagnostic devices and testing kits, through government contracts, hospitals, and healthcare facilities, where bulk purchases are made based on specific tender requirements. This channel is particularly prominent in large-scale healthcare settings and public health programs. On the other hand, retail sales cater to the consumer market, including pharmacies, online platforms, and direct-to-consumer sales, where individuals can purchase over-the-counter urinalysis products, such as dipsticks and home testing kits, for personal use. The growth of e-commerce and the increasing preference for home-based testing are expected to boost the retail sales channel, complementing the steady demand from direct tender markets.
Urinalysis Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
North America is expected to dominate the urinalysis market over the forecast period, driven by advanced healthcare infrastructure, high awareness of preventive healthcare, and widespread adoption of urinalysis in routine diagnostics. The United States, in particular, has a well-established healthcare system with strong demand for diagnostic testing, including for conditions such as diabetes, kidney diseases, and urinary tract infections. Additionally, significant investments in research and development, along with technological advancements in automated and digital urinalysis systems, further propel market growth in this region. With increasing focus on early disease detection and management, North America is poised to maintain its leadership in the global urinalysis market.
Active Key Players in the Urinalysis Market
- 77 Elektronika Kft. (Hungary)
- Abbott (US)
- ACON Laboratories, Inc. (US)
- Agappe Diagnostics Ltd (India)
- Alphatec Scientific E.I.R.L. (Peru)
- Analyticon Biotechnologies GmbH (Germany)
- Arkray, Inc. (Japan)
- Becton, Dickinson and Company (US)
- BIOBASE Group (China)
- Biocare Corporation (Taiwan)
- Biopanda Reagents Ltd. (UK)
- Bio-Rad Laboratories, Inc. (US)
- Bioway Biological Technology Co., Ltd. (China)
- Cardinal Health (US)
- Contec Medical Systems Co., Ltd. (China)
- Danaher (US)
- DIALAB GmbH (Austria)
- Dirui Industrial Co., Ltd. (China)
- EKF Diagnostics Holdings PLC (UK)
- Erba Mannheim (Germany)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- High Technology, Inc. (US)
- PZ Cormay S.A. (Poland)
- Quantimetrix (US)
- QuidelOrtho Corporation (US)
- Randox Laboratories Ltd. (UK)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- Siemens Healthineers AG (Germany)
- Sysmex Corporation (Japan)
- Teco Diagnostics (US)
- Thermo Fisher Scientific (US)
- Toyobo Co., Ltd. (Japan)
- URIT Medical Electronic Co., Ltd. (China)
- YD Diagnostics (South Korea)
- Others Active Players.
|
Urinalysis Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 4.16 Billion |
|
Forecast Period 2024-32 CAGR: |
8.92% |
Market Size in 2032: |
USD 8.98 Billion |
|
Segments Covered: |
By Testing Type |
|
|
|
By Product |
|
||
|
By Modality |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Distribution Channel |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Urinalysis Market by Testing Type
4.1 Urinalysis Market Snapshot and Growth Engine
4.2 Urinalysis Market Overview
4.3 Urine Biochemistry Testing and Urine Sediment Testing)
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Urine Biochemistry Testing and Urine Sediment Testing): Geographic Segmentation Analysis
4.4 Product
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Product : Geographic Segmentation Analysis
Chapter 5: Urinalysis Market by Application
5.1 Urinalysis Market Snapshot and Growth Engine
5.2 Urinalysis Market Overview
5.3 Urinary Tract Infections
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Urinary Tract Infections: Geographic Segmentation Analysis
5.4 Kidney Diseases
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Kidney Diseases: Geographic Segmentation Analysis
5.5 Diabetes
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Diabetes: Geographic Segmentation Analysis
5.6 Liver Diseases
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Liver Diseases: Geographic Segmentation Analysis
5.7 Pregnancy and Fertility and Others)
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Pregnancy and Fertility and Others): Geographic Segmentation Analysis
5.8
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 : Geographic Segmentation Analysis
Chapter 6: Urinalysis Market by End User
6.1 Urinalysis Market Snapshot and Growth Engine
6.2 Urinalysis Market Overview
6.3 Hospital
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital: Geographic Segmentation Analysis
6.4 Laboratory
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Laboratory: Geographic Segmentation Analysis
6.5 Home Care Setting and Others)
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Home Care Setting and Others): Geographic Segmentation Analysis
6.6
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 : Geographic Segmentation Analysis
Chapter 7: Urinalysis Market by Distribution Channel
7.1 Urinalysis Market Snapshot and Growth Engine
7.2 Urinalysis Market Overview
7.3 Direct Tender and Retail Sales)
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Direct Tender and Retail Sales) : Geographic Segmentation Analysis
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Urinalysis Market Share by Manufacturer (2023)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 SIEMENS HEALTHINEERS AG (GERMANY)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND)
8.4 CARDINAL HEALTH (US)
8.5 DANAHER (US)
8.6 ABBOTT (US)
8.7 SYSMEX CORPORATION (JAPAN)
8.8 THERMO FISHER SCIENTIFIC (US)
8.9 QUIDELORTHO CORPORATION (US)
8.10 BECTON
8.11 DICKINSON AND COMPANY (US)
8.12 BIO-RAD LABORATORIES INC. (US)
8.13 EKF DIAGNOSTICS HOLDINGS PLC (UK)
8.14 ARKRAY INC. (JAPAN)
8.15 ACON LABORATORIES INC. (US)
8.16 77 ELEKTRONIKA KFT. (HUNGARY)
8.17 URIT MEDICAL ELECTRONIC CO. LTD. (CHINA)
8.18 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD. (CHINA)
8.19 DIRUI INDUSTRIAL CO. LTD. (CHINA)
8.20 BIOBASE GROUP (CHINA)
8.21 ERBA MANNHEIM (GERMANY)
8.22 ALPHATEC SCIENTIFIC E.I.R.L. (PERU)
8.23 TECO DIAGNOSTICS (US)
8.24 ANALYTICON BIOTECHNOLOGIES GMBH (GERMANY)
8.25 BIOWAY BIOLOGICAL TECHNOLOGY CO. LTD. (CHINA)
8.26 HIGH TECHNOLOGY INC. (US)
8.27 AGAPPE DIAGNOSTICS LTD (INDIA)
8.28 TOYOBO CO. LTD. (JAPAN)
8.29 DIALAB GMBH (AUSTRIA)
8.30 QUANTIMETRIX (US)
8.31 BIOCARE CORPORATION (TAIWAN)
8.32 RANDOX LABORATORIES LTD. (UK)
8.33 PZ CORMAY S.A. (POLAND)
8.34 YD DIAGNOSTICS (SOUTH KOREA)
8.35 CONTEC MEDICAL SYSTEMS CO. LTD. (CHINA)
8.36 BIOPANDA REAGENTS LTD. (UK)
8.37 OTHER ACTIVE PLAYERS
Chapter 9: Global Urinalysis Market By Region
9.1 Overview
9.2. North America Urinalysis Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size By Testing Type
9.2.4.1 Urine Biochemistry Testing and Urine Sediment Testing)
9.2.4.2 Product
9.2.5 Historic and Forecasted Market Size By Application
9.2.5.1 Urinary Tract Infections
9.2.5.2 Kidney Diseases
9.2.5.3 Diabetes
9.2.5.4 Liver Diseases
9.2.5.5 Pregnancy and Fertility and Others)
9.2.5.6
9.2.6 Historic and Forecasted Market Size By End User
9.2.6.1 Hospital
9.2.6.2 Laboratory
9.2.6.3 Home Care Setting and Others)
9.2.6.4
9.2.7 Historic and Forecasted Market Size By Distribution Channel
9.2.7.1 Direct Tender and Retail Sales)
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Urinalysis Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size By Testing Type
9.3.4.1 Urine Biochemistry Testing and Urine Sediment Testing)
9.3.4.2 Product
9.3.5 Historic and Forecasted Market Size By Application
9.3.5.1 Urinary Tract Infections
9.3.5.2 Kidney Diseases
9.3.5.3 Diabetes
9.3.5.4 Liver Diseases
9.3.5.5 Pregnancy and Fertility and Others)
9.3.5.6
9.3.6 Historic and Forecasted Market Size By End User
9.3.6.1 Hospital
9.3.6.2 Laboratory
9.3.6.3 Home Care Setting and Others)
9.3.6.4
9.3.7 Historic and Forecasted Market Size By Distribution Channel
9.3.7.1 Direct Tender and Retail Sales)
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Urinalysis Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size By Testing Type
9.4.4.1 Urine Biochemistry Testing and Urine Sediment Testing)
9.4.4.2 Product
9.4.5 Historic and Forecasted Market Size By Application
9.4.5.1 Urinary Tract Infections
9.4.5.2 Kidney Diseases
9.4.5.3 Diabetes
9.4.5.4 Liver Diseases
9.4.5.5 Pregnancy and Fertility and Others)
9.4.5.6
9.4.6 Historic and Forecasted Market Size By End User
9.4.6.1 Hospital
9.4.6.2 Laboratory
9.4.6.3 Home Care Setting and Others)
9.4.6.4
9.4.7 Historic and Forecasted Market Size By Distribution Channel
9.4.7.1 Direct Tender and Retail Sales)
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Urinalysis Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size By Testing Type
9.5.4.1 Urine Biochemistry Testing and Urine Sediment Testing)
9.5.4.2 Product
9.5.5 Historic and Forecasted Market Size By Application
9.5.5.1 Urinary Tract Infections
9.5.5.2 Kidney Diseases
9.5.5.3 Diabetes
9.5.5.4 Liver Diseases
9.5.5.5 Pregnancy and Fertility and Others)
9.5.5.6
9.5.6 Historic and Forecasted Market Size By End User
9.5.6.1 Hospital
9.5.6.2 Laboratory
9.5.6.3 Home Care Setting and Others)
9.5.6.4
9.5.7 Historic and Forecasted Market Size By Distribution Channel
9.5.7.1 Direct Tender and Retail Sales)
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Urinalysis Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size By Testing Type
9.6.4.1 Urine Biochemistry Testing and Urine Sediment Testing)
9.6.4.2 Product
9.6.5 Historic and Forecasted Market Size By Application
9.6.5.1 Urinary Tract Infections
9.6.5.2 Kidney Diseases
9.6.5.3 Diabetes
9.6.5.4 Liver Diseases
9.6.5.5 Pregnancy and Fertility and Others)
9.6.5.6
9.6.6 Historic and Forecasted Market Size By End User
9.6.6.1 Hospital
9.6.6.2 Laboratory
9.6.6.3 Home Care Setting and Others)
9.6.6.4
9.6.7 Historic and Forecasted Market Size By Distribution Channel
9.6.7.1 Direct Tender and Retail Sales)
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Urinalysis Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size By Testing Type
9.7.4.1 Urine Biochemistry Testing and Urine Sediment Testing)
9.7.4.2 Product
9.7.5 Historic and Forecasted Market Size By Application
9.7.5.1 Urinary Tract Infections
9.7.5.2 Kidney Diseases
9.7.5.3 Diabetes
9.7.5.4 Liver Diseases
9.7.5.5 Pregnancy and Fertility and Others)
9.7.5.6
9.7.6 Historic and Forecasted Market Size By End User
9.7.6.1 Hospital
9.7.6.2 Laboratory
9.7.6.3 Home Care Setting and Others)
9.7.6.4
9.7.7 Historic and Forecasted Market Size By Distribution Channel
9.7.7.1 Direct Tender and Retail Sales)
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
|
Urinalysis Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 4.16 Billion |
|
Forecast Period 2024-32 CAGR: |
8.92% |
Market Size in 2032: |
USD 8.98 Billion |
|
Segments Covered: |
By Testing Type |
|
|
|
By Product |
|
||
|
By Modality |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Distribution Channel |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
